In cases of acute promyelocytic leukemia (APL), the PML-RARα fusion gene has been proven to be the driver gene, and thereby, chemical agents targeting this gene show a therapeutic effect 41. The gene discussed is PML; the disease is acute promyelocytic leukemia.